Publications
This section collects the most significant scientific contents of EGOI-PCOS members concerning the use of inositols alone or in association, both in basic research and for clinical application.
Also, the most relevant and updated literature on diagnosis and therapy of PCOS is gathered.
In particular, this collection includes the most recent original articles, clinical trials, reviews and meta-analyzes on the use of inositols especially in the gynecological, reproductive, metabolic, and endocrine fields.
Manuscripts inserted deal with important issues such as Polycystic Ovary Syndrome (PCOS), metabolic syndrome, insulin resistance, gestational diabetes with its complications, neurological defects for the unborn children linked to the nutritional deficiencies of mothers.
Myo-inositol impact on sperm motility in vagina and evaluation of its effects on foetal development
Authors: M. Montanino Oliva, G. Buonomo, M.C. Carra, A. Lippa, F. Lisi
Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?
Authors: Bizzarri M, Laganà AS, Aragona D, Unfer V.
Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial
Authors: Leila Nazaria, Saghar Salehpourb, Sedigheh Hosseinib, Nasrin Saharkhizb, Elham Azizic, Teibeh Hashemia, Robabeh Ghodssi-Ghassemabadid
A double-edge sword: the role of D-chiro-inositol in oocyte and embryo quality
Authors: M. Minini, G. Monastra, S. Dinicola
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review
Authors: D’Anna R, Santamaria A, Alibrandi A, Corrado F, DI Benedetto A, Facchinetti F
Efficacy of the synergic action of myoinositol, tyrosine, selenium and chromium in women with PCOS
Authors: Montanino Oliva M, Zuev V, Lippa A, Carra MC, Lisi F.
Anticancer Properties of Inositol Hexaphosphate and Inositol: An Overview
Authors: Vucenik I
Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors
Authors: Garzon S, Laganà AS, Monastra G
New perspectives on male fertility evaluation: Innovative approach for the qualitative analysis of spermatozoa
Authors: Bezerra Espinola MS, Aragona C
The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
Authors: M. Nordio, S. Basciani, E. Camajani